|
시장보고서
상품코드
2107781
식물 유래 바이오의약품 시장 : 제품 유형별, 원료 유형별, 적응 질환별, 지역별Plant-Based Biologics Market, By Product Type, By Source Type, By Disease Indication, By Geography |
||||||
식물 유래 바이오의약품 시장은 2026년에 2,370만 달러 규모에 달할 것으로 추정되고 있으며, 2033년까지 3,000만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 3.4%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 2,370만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 3.40% | 2033년 시장 규모 예측 : | 3,000만 달러 |
식물 유래 바이오의약품이란 식물 분자 농업을 이용하여 제조되는 바이오의약품을 말합니다. 이들은 식물 유래 바이오의약품(PMB)으로도 알려져 있습니다. 식물 유래 바이오의약품의 용도와 이점은 기존의 백신이나 치료용 단백질의 범위를 넘어 확장되고 있습니다. 예를 들어 2015년에 식물 유래 세균성 콜리신이 식품내 병원균을 억제하는 식품 첨가물로서 유효하다는 사실이 최근 입증되었습니다. 이러한 콜리신은 식중독을 유발하는 모든 병원성 대장균 균주에 대해(저농도로 사용하더라도) 매우 높은 효과를 발휘합니다. 또한 정제된 콜리신 1그램의 제조 비용은 약 1달러로, 상업적으로도 실현 가능합니다.
시장 역학
다양한 만성질환에 대한 바이오의약품 수요 증가와 바이오의약품 생산을 위한 연구개발(R&D) 투자 확대가 식물 유래 바이오의약품 시장의 성장에 크게 기여할 것으로 예상됩니다. 예를 들어 바이오테크놀러지 혁신 기구(BIO)의 2015년 보고서에 따르면 250종 이상의 생물제제 및 백신이 수억 명의 환자의 삶을 완전히 바꿔 놓았습니다. 또한 같은 출처에 따르면 현재(2018년) 미국에서는 100개 이상의 질환을 대상으로 900종 이상의 생물제제가 개발 단계에 있습니다. 또한 미국제약산업협회(PhRMA)의 2016년 보고서에 따르면 회원사들은 2015년에 연구개발에 약 588억 달러를 투자했으며, 그중 대부분은 미국의 모든 바이오의약품 기업이 희귀 질환 치료를 위해 투자한 금액이었습니다.
많은 바이오의약품 기업은 담배, 개구리밥, 이끼, 알팔파 등 다양한 식물을 활용한 식물 유래 의약품 개발에 주력하고 있으며, 이는 식물 유래 바이오의약품 시장의 성장을 촉진할 것으로 기대됩니다. 예를 들어 2015년 9월, Mapp Biopharmaceutical, Inc.(Mapp)의 상업적 파트너인 LeafBio, Inc.는 에볼라 바이러스병 치료제로 개발중인 식물 유래 의약품 ‘ZMapp’에 대해 미국 식품의약국(FDA)으로부터 패스트트랙 지정을 받았습니다.
그러나 식물 유래 바이오의약품 제조에 관한 엄격한 규제 지침은 해당 시장의 성장을 저해하는 주요 요인 중 하나입니다. 또한 오염 및 환경 위험에 대한 우려도 시장 성장을 저해하는 요인으로 작용하고 있습니다.
본 조사의 주요 특징
- 본 조사에서는 다양한 부문별 잠재적 수익 기회를 규명하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 해설하고 있습니다.
- 또한 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업이 채택하고 있는 경쟁 전략에 관한 중요 인사이트도 제공합니다.
- 본 조사에서는 다음 매개변수를 바탕으로 전 세계 식물 유래 바이오의약품 시장의 주요 기업 개요을 작성했습니다. : 기업 개요, 재무 실적, 제품 포트폴리오, 사업 전개 지역, 유통 전략, 주요 발전 사항 및 전략.
- 이 보고서에서 얻은 인사이트를 통해 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 정부 정책, 기술 업그레이드, 시장 확대 및 마케팅 전략에 대해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 ‘세계의 식물 유래 바이오의약품 시장’ 보고서는 투자자, 제품 제조사, 유통업체, 공급업체를 비롯해 조사·컨설팅 회사, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 개요
제3장 시장 역학·규제·동향 분석
제4장 세계의 식물 유래 바이오의약품 시장 : 제품 유형별, 2021-2033년
제5장 세계의 식물 유래 바이오의약품 시장 : 원료 유형별, 2021-2033년
제6장 세계의 식물 유래 바이오의약품 시장 : 질환 적응증별, 2021-2033년
제7장 세계의 식물 유래 바이오의약품 시장 : 지역별, 2021-2033년
제8장 경쟁 구도
제9장 섹션
KSA 26.08.12Plant-Based Biologics Market is estimated to be valued at USD 23.7 Mn in 2026 and is expected to reach USD 30.0 Mn by 2033, growing at a compound annual growth rate (CAGR) of 3.4% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 23.7 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 3.40% | 2033 Value Projection: | USD 30.0 Mn |
Plant-based biologics are biologic drugs that are manufactured by using plant molecular farming. They are also known as plant-made biologics (PMB). The applications and advantages of plant-based biologics have stretched beyond the traditional boundaries of vaccines and therapeutic proteins. For instance, bacterial colicins derived from plants in 2015 were recently proven effective as food additives for controlling pathogenic bacteria in food products. These colicins are highly effective (even when used in lower concentrations) to fight against all the pathogenic Escherichia coli strains that cause food poisoning. Moreover, it costs around US$ 1.00 for manufacturing one gram of purified colicins, which is commercially viable.
Market Dynamics
The increasing demand for biologics for various chronic diseases and rising investments in R&D for the production of biologics are expected to contribute significantly to the growth of plant-based biologics market. For instance, according to the Biotechnology Innovation Organization (BIO) 2015, over 250 biologic therapies and vaccines have changed the lives of hundreds of millions of patients. Moreover, according to the same source, over 900 biologics are currently (2018) under the stage of development for over 100 diseases in the U.S. Furthermore, according to the Pharmaceutical Research and Manufacturers of America (PhRMA), 2016, member companies invested around US$ 58.8 billion in research and development in 2015, of which, majority of the investments was made by all the biopharmaceutical companies in the U.S. for the treatment of rare diseases.
Many biopharmaceutical companies are focused on developing plant-made pharmaceuticals using various plants such as tobacco, duckweed, moss, alfalfa, and other plants, which is expected to propel growth of the plant-based biologics market. For instance, in September 2015, LeafBio, Inc., the commercial partner of Mapp Biopharmaceutical, Inc. (Mapp), was granted fast track designation by the U.S. Food and Drug Administration (FDA) for their plant-made drug ZMapp for the treatment of Ebola virus disease.
However, stringent regulatory guidelines for the production of plant-based biologics is one of the major factors restraining growth of the plant-based biologics market. Moreover, concern regarding contamination and environmental risks is another factor restraining growth of the market.
Key features of the study
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players
- It profiles key players in the global plant-based biologics market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
- Key players covered as a part of this study include Leaf Expression Systems, Zea Biosciences, Planet Biotechnology Inc., InVitria, PlantForm Corporation, IBIO, Inc., Mapp Biopharmaceutical, Inc., Pfizer Inc., Ventria Bioscience Inc., Medicago Inc., Eleva GmbH, Kentucky Bioprocessing, LLC, Solarvest Bioenergy Inc., and Byondis B.V.
- Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
- The global plant-based biologics market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for plant-based biologics market, research and consulting firms, new entrants, and financial analysts.
Market Segmentation
- By Product Type (Revenue, USD Mn, 2021-2033)
- Monoclonal Antibodies
- Alpha Interferon
- Glucocerebrosidase
- Vaccines
- Others
- By Source Type (Revenue, USD Mn, 2021-2033)
- Carrot
- Tobacco Leaves
- Rice Seeds
- Alfalfa
- Others
- By Disease Indication (Revenue, USD Mn, 2021-2033)
- Gaucher Disease
- Tooth Decay
- Hepatitis
- Lymphoma
- Others
- By Region (Revenue, USD Mn, 2021-2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Key Players
- Leaf Expression Systems
- Zea Biosciences
- Planet Biotechnology Inc.
- InVitria
- PlantForm Corporation
- IBIO, Inc.
- Mapp Biopharmaceutical, Inc.
- Pfizer Inc.
- Ventria Bioscience Inc.
- Medicago Inc.
- Eleva GmbH
- Kentucky Bioprocessing, LLC
- Solarvest Bioenergy Inc.
- Byondis B.V.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Source Type
- Market Snapshot, By Disease Indication
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Product Approval
- Collaboration/Merge/Acquisition
- Regulatory Landscape
- PEST Analysis
- Porter's Five Forces Analysis
- Epidemiology
- Robust Pipeline Analysis
4. Global Plant-Based Biologics Market, By Product Type, 2021 - 2033, (USD Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
- Monoclonal Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
- Alpha Interferon
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
- Glucocerebrosidase
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
- Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
5. Global Plant-Based Biologics Market, By Source Type, 2021 - 2033, (USD Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
- Carrot
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
- Tobacco Leaves
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
- Rice Seeds
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
- Alfalfa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
6. Global Plant-Based Biologics Market, By Disease Indication, 2021 - 2033, (USD Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
- Gaucher Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
- Tooth Decay
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
- Hepatitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
- Lymphoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
7. Global Plant-Based Biologics Market, By Region, 2021 - 2033, (USD Million)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Million)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Million)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Million)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Company Profile
- Leaf Expression Systems
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Zea Biosciences
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Planet Biotechnology Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- InVitria
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- PlantForm Corporation
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- IBIO, Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Mapp Biopharmaceutical, Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Ventria Bioscience Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Medicago Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Eleva GmbH
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Kentucky Bioprocessing, LLC
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Solarvest Bioenergy Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Byondis B.V.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Leaf Expression Systems
- Analyst Views
9. Section
- References
- Research Methodology
- About Us
